PAPER Picard C, Miron J, Poirier J
SEARCH RESULTS
1361 RESULTS
PAPER Ramos R, Vale N
Dual Drug Repurposing: The Example of Saracatinib.
Int J Mol Sci. 2024 Apr 22;25(8) PubMed: 38674150PAPER Lewitt MS, Boyd GW
Role of the Insulin-like Growth Factor System in Neurodegenerative Disease.
Int J Mol Sci. 2024 Apr 20;25(8) PubMed: 38674097PAPER Plachokova AS, Gjaltema J, Hagens ER, Hashemi Z, Knüppe TB, Kootstra TJ, Visser A, Bloem BR
Periodontitis: A Plausible Modifiable Risk Factor for Neurodegenerative Diseases? A Comprehensive Review.
Int J Mol Sci. 2024 Apr 19;25(8) PubMed: 38674088PAPER Saponjic J, Mejías R, Nikolovski N, Dragic M, Canak A, Papoutsopoulou S, Gürsoy-Özdemir Y, Fladmark KE, Ntavaroukas P, Bayar Muluk N, Zeljkovic Jovanovic M, Fontán-Lozano Á, Comi C, Marino F
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
Int J Mol Sci. 2024 Apr 14;25(8) PubMed: 38673915PAPER Liu Z, Chen Y, Chen Y, Zheng J, Wu W, Wang L, Wang H, Yu Y
Effect of Regulation of Chemerin/Chemokine-like Receptor 1/Stimulator of Interferon Genes Pathway on Astrocyte Recruitment to Aβ Plaques.
Int J Mol Sci. 2024 Apr 13;25(8) PubMed: 38673909PAPER Agnello L, Gambino CM, Ciaccio AM, Masucci A, Vassallo R, Tamburello M, Scazzone C, Lo Sasso B, Ciaccio M
Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice.
Int J Mol Sci. 2024 Apr 13;25(8) PubMed: 38673907PAPER Pérez Gutiérrez RM, Rodríguez-Serrano LM, Laguna-Chimal JF, de la Luz Corea M, Paredes Carrera SP, Téllez Gomez J
Geniposide and Harpagoside Functionalized Cerium Oxide Nanoparticles as a Potential Neuroprotective.
Int J Mol Sci. 2024 Apr 11;25(8) PubMed: 38673848PAPER Kiss E, Kins S, Gorgas K, Venczel Szakács KH, Kirsch J, Kuhse J
Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer's Disease.
Int J Mol Sci. 2024 Apr 9;25(8) PubMed: 38673751PAPER Machado Reyes D, Chao H, Hahn J, Shen L, Yan P, For The Alzheimer's Disease Neuroimaging Initiative
Identifying Progression-Specific Alzheimer's Subtypes Using Multimodal Transformer.
J Pers Med. 2024 Apr 15;14(4) PubMed: 38673048PAPER Wani I, Koppula S, Balda A, Thekkekkara D, Jamadagni A, Walse P, Manjula SN, Kopalli SR
An Update on the Potential of Tangeretin in the Management of Neuroinflammation-Mediated Neurodegenerative Disorders.
Life (Basel). 2024 Apr 14;14(4) PubMed: 38672774PAPER Lachén-Montes M, Cartas-Cejudo P, Cortés A, Anaya-Cubero E, Peral E, Ausín K, Díaz-Peña R, Fernández-Irigoyen J, Santamaría E
Involvement of Glucosamine 6 Phosphate Isomerase 2 (GNPDA2) Overproduction in β-Amyloid- and Tau P301L-Driven Pathomechanisms.
Biomolecules. 2024 Mar 25;14(4) PubMed: 38672412PAPER Altay O, Yang H, Yildirim S, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Shoaie S, Zhang C, Borén J, Uhlén M, Turkez H, Mardinoglu A
Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases.
Biomedicines. 2024 Apr 22;12(4) PubMed: 38672280PAPER Niazi SK, Magoola M
Transcytosis-Driven Treatment of Neurodegenerative Disorders by mRNA-Expressed Antibody-Transferrin Conjugates.
Biomedicines. 2024 Apr 12;12(4) PubMed: 38672205PAPER Jarek DJ, Mizerka H, Nuszkiewicz J, Szewczyk-Golec K